Singapore, June 2025 – ChemT Biotechnology has been selected for the BioTools Innovator 2025 Accelerator Program, one of the world’s leading accelerators for the biotech sector. This year’s program saw over 420 applicants from around the globe, with only 30 companies chosen — making ChemT the first Singapore-based company in the program’s history.

Running from June to November 2025, the BioTools Innovator Accelerator connects participants with world-class mentors, strategic partners, and investors, culminating in a high-profile capstone event. The program supports innovators developing cutting-edge tools and technologies that advance life sciences research, diagnostics, and biomanufacturing.